Urosphere at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Urosphere brings 2 presentations to ENA 2026 in Barcelona. Its posters cover patient-derived xenograft and organoid models used to study drug response and resistance. They trace acquired resistance to olaparib and enfortumab vedotin in genitourinary cancers and show that matched breast cancer xenografts and organoids keep the molecular landscape and drug response of the tumors they come from.
| Organization | ENA 2026 Attendance |
|---|---|
Urosphere Toulouse, France | |
Preclinical contract research company offering urology and oncology models, including patient-derived xenografts and organoids. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from Urosphere
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction